http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2925348-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_397384a6d230e34cf9e18e9c7d9b0a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d33087dfb06f23a561b692aecc073feb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4b82933a5e654ee8cfd175ff11b6f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c383623644393e54bd9edfc5e75b9187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7351ddf252d8bc6ef8b4e50e57632fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c9d4c64ba4efe4b6855c7fd2a7ada9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c68576646fb36122ec2d142fd80af07
publicationDate 2019-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2925348-B1
titleOfInvention Individualized vaccines for cancer
priorityDate 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467618544

Total number of triples: 26.